Utilising survey data to inform public policy: Comparison of the cost-effectiveness of treatment of ten mental disorders

Background Mental health survey data are now being used proactively to decide how the burden of disease might best be reduced. Aims To study the cost-effectiveness of current and optimal treatments for mental disorders and the proportion of burden avertable by each. Method Data for three affective, four anxiety and two alcohol use disorders and for schizophrenia were compared in terms of cost, burden averted and efficiency of current and optimal treatment. We then calculated the burden unavertable given current knowledge. The unit of health gain was a reduction in the years lived with disability (YLDs). Results Summing across all disorders, current treatment averted 13% of the burden, at an average cost of AUS$30 000 per YLD gained. Optimal treatment at current coverage could avert 20% of the burden, at an average cost of AUS$18 000 per YLD gained. Optimal treatment at optimal coverage could avert 28% of the burden, at AUS$16 000 per YLD gained. Sixty per cent of the burden of mental disorders was deemed to be unavertable. Conclusions The efficiency of treatment varied more than tenfold across disorders. Although coverage of some of the more efficient treatments should be extended, other factors justify continued use of less-efficient treatments for some disorders.

[1]  R. Kessler The World Health Organization International Consorthm in Psychiatric Epidemiology (ICPE): initial work and future directions ‐ the NAPE Lecture 1998 a , 1999 .

[2]  R. Rosenheck,et al.  Principles for priority setting in mental health services and their implications for the least well off. , 1999, Psychiatric services.

[3]  I. Hickie,et al.  Summary of Guideline for the Treatment of Depression , 2003 .

[4]  J. Castro The Price of Mental Health , 1965, Time.

[5]  W. Katon,et al.  Depression, anxiety, and social disability show synchrony of change in primary care patients. , 1993, American journal of public health.

[6]  J. Lonnqvist,et al.  Antidepressant efficacy and quality of life in depression: a double‐blind study with moclobemide and fluoxetine , 1994, Acta psychiatrica Scandinavica.

[7]  G. Andrews Randomised controlled trials in psychiatry: important but poorly accepted , 1999, BMJ.

[8]  G. Andrews,et al.  The economic costs of schizophrenia. Implications for public policy. , 1985, Archives of general psychiatry.

[9]  W. Jack Public spending on health care: how are different criteria related? A second opinion. , 2000, Health Policy.

[10]  G. Andrews,et al.  Summary of Guideline for the Treatment of Panic Disorder and Agoraphobia , 2003 .

[11]  C. Mihalopoulos Assessing cost-effectiveness in mental health , 2004 .

[12]  R. Warner How much of the burden of schizophrenia is alleviated by treatment? , 2003, British Journal of Psychiatry.

[13]  G. Andrews,et al.  Using epidemiological data to model efficiency in reducing the burden of depression* , 2000, The journal of mental health policy and economics.

[14]  M. Teesson,et al.  Who seeks treatment for alcohol dependence? , 2002, Social Psychiatry and Psychiatric Epidemiology.

[15]  John W. Finney,et al.  Brief Interventions for Alcohol Problems , 2004, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[16]  D M Steinwachs,et al.  Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. , 1998, Schizophrenia bulletin.

[17]  G. Andrews,et al.  Prevalence, comorbidity, disability and service utilisation , 2001, British Journal of Psychiatry.

[18]  G. Andrews,et al.  Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders , 2004, Psychological Medicine.

[19]  A. Maynard,et al.  Rationing health care: an exploration. , 1999, Health policy.

[20]  R. Goldney Guidelines for the treatment of depression. , 2004, The Australian and New Zealand journal of psychiatry.

[21]  D. Goldberg Invited commentary on: Cost-effectiveness of current and optimal treatment for schizophrenia , 2003, British Journal of Psychiatry.

[22]  D S Rae,et al.  Congruence of service utilization estimates from the Epidemiologic Catchment Area Project and other sources. , 1993, Archives of general psychiatry.

[23]  D Castle,et al.  Psychotic Disorders in Urban Areas: An Overview of the Study on Low Prevalence Disorders , 2000, The Australian and New Zealand journal of psychiatry.

[24]  G. Andrews,et al.  Deconstructing current comorbidity: data from the Australian National Survey of Mental Health and Well-Being , 2002, British Journal of Psychiatry.

[25]  J. Finney,et al.  Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. , 2002, Addiction.

[26]  G. Andrews,et al.  The Treatment of Anxiety Disorders: Clinician Guides and Patient Manuals , 1995 .

[27]  S. Faraone,et al.  The concept of target features in schizophrenia research , 1999, Acta psychiatrica Scandinavica. Supplementum.

[28]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[29]  H. Barker Randomised controlled trials in psychiatry , 2000, BMJ : British Medical Journal.

[30]  P. Musgrove Public spending on health care: how are different criteria related? , 1999, Health policy.

[31]  Alan D. Lopez,et al.  The burden of disease and injury in Australia. , 2001, Bulletin of the World Health Organization.

[32]  G. Andrews,et al.  Using the effect size to model change in preference values from descriptive health status , 2004, Quality of Life Research.

[33]  G. Andrews,et al.  Evidence-based care for alcohol use disorders is affordable. , 2004, Journal of studies on alcohol.

[34]  G. Andrews,et al.  Cost-effectiveness of current and optimal treatment for schizophrenia , 2003, British Journal of Psychiatry.

[35]  M. Mcgrath Cost Effectiveness in Health and Medicine. , 1998 .

[36]  K. Calman The ethics of allocation of scarce health care resources: a view from the centre. , 1994, Journal of medical ethics.

[37]  G. Andrews,et al.  Reducing the burden of affective disorders: is evidence-based health care affordable? , 2003, Journal of affective disorders.